Gongwin Biopharm Holdings Co (ROCO:6617) FCF Margin %: -481.77% (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ROCO:6617 Gongwin Biopharm Holdings Co Ltd ROCO:6617
57 GF Score
Price NT$123.00
! 5 Warning Signs
View Full Analysis

What is Gongwin Biopharm Holdings Co FCF Margin %?

Gongwin Biopharm Holdings Co ROCO:6617 +8.37% 57 FCF Margin % is -481.77% as of Jun. 2026. GuruFocus rates ROCO:6617 with a GF Score™ of 57/100. The stock has 5 warning signs investors should review. Among 960 Biotechnology companies, Gongwin Biopharm Holdings Co ranks worse than 71.25% on this metric.

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Gongwin Biopharm Holdings Co's Free Cash Flow for the three months ended in Jun. 2026 was NT$-61.11 Mil. Gongwin Biopharm Holdings Co's Revenue for the three months ended in Jun. 2026 was NT$12.69 Mil. Therefore, Gongwin Biopharm Holdings Co's FCF Margin % for the quarter that ended in Jun. 2026 was -481.77%.

As of today, Gongwin Biopharm Holdings Co's current FCF Yield % is -1.33%.

The historical rank and industry rank for Gongwin Biopharm Holdings Co's FCF Margin % or its related term are showing as below:

ROCO:6617' s FCF Margin % Range Over the Past 10 Years
Min: -270345.16   Med: -12222.13   Max: -379.22
Current: -471

During the past 13 years, the highest FCF Margin % of Gongwin Biopharm Holdings Co was -379.22%. The lowest was -270345.16%. And the median was -12222.13%.

ROCO:6617's FCF Margin % is ranked worse than
71.25% of 960 companies
in the Biotechnology industry
Industry Median: -77.165 vs ROCO:6617: -471.00

Gongwin Biopharm Holdings Co FCF Margin % Related Terms

Gongwin Biopharm Holdings Co FCF Margin % Historical Data

* Premium members only.

The historical data trend for Gongwin Biopharm Holdings Co's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Gongwin Biopharm Holdings Co FCF Margin % Chart

Gongwin Biopharm Holdings Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
FCF Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -8,360.63 -20,854.77 -591.73 -916.16 -379.22

Gongwin Biopharm Holdings Co Quarterly Data
Dec20 Jun21 Dec21 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
FCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -189.70 -324.79 -717.14 -438.89 -481.77

ROCO:6617 vs VRTX, REGN, MRNA: FCF Margin % Comparison

For the Biotechnology subindustry, Gongwin Biopharm Holdings Co's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Gongwin Biopharm Holdings Co FCF Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Gongwin Biopharm Holdings Co's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Gongwin Biopharm Holdings Co's FCF Margin % falls into.


ROCO:6617
57GF Score
Gongwin Biopharm Holdings Co Ltd ROCO:6617
FCF Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Gongwin Biopharm Holdings Co FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Gongwin Biopharm Holdings Co's FCF Margin for the fiscal year that ended in Dec. 2025 is calculated as

FCF Margin=Free Cash Flow (A: Dec. 2025 )/Revenue (A: Dec. 2025 )
=-138.211/36.446
=-379.22 %

Gongwin Biopharm Holdings Co's FCF Margin for the quarter that ended in Jun. 2026 is calculated as

FCF Margin=Free Cash Flow (Q: Jun. 2026 )/Revenue (Q: Jun. 2026 )
=-61.112/12.685
=-481.77 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about FCF Margin % →
What does a FCF Margin % of -481.77% mean?
Gongwin Biopharm Holdings Co (ROCO:6617) has a FCF Margin % of -481.77% as of Jun. 2026. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Gongwin Biopharm Holdings Co and its competitors. According to the industry distribution chart, Gongwin Biopharm Holdings Co ranks #684 out of 960 companies in the Biotechnology industry, placing it in the top 71.2%.
Is Gongwin Biopharm Holdings Co's FCF Margin % too high?
Gongwin Biopharm Holdings Co's current FCF Margin % is -481.77%. Based on the distribution chart, Gongwin Biopharm Holdings Co ranks #684 out of 960 companies in the Biotechnology industry, which is below the industry midpoint. Overall, Gongwin Biopharm Holdings Co has a GF Score™ of 57/100, reflecting its overall financial health beyond just this single metric.
How does Gongwin Biopharm Holdings Co's FCF Margin % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Gongwin Biopharm Holdings Co ranks #684 out of 960 companies for FCF Margin %. This places Gongwin Biopharm Holdings Co in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Biotechnology company?
A good FCF Margin % depends on the Biotechnology industry context. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Gongwin Biopharm Holdings Co and its competitors. Gongwin Biopharm Holdings Co's current FCF Margin % is -481.77%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Gongwin Biopharm Holdings Co stock overvalued right now?
Gongwin Biopharm Holdings Co (ROCO:6617) has a current FCF Margin % of -481.77%. The current FCF Margin % is -481.77%. Gongwin Biopharm Holdings Co's overall GF Score™ is 57/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Gongwin Biopharm Holdings Co (ROCO:6617), the current FCF Margin % is -481.77% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Gongwin Biopharm Holdings Co Business Description

Address 3rd Floor, No.80, Jianguo North Road, Section 1, Zongshan District, Taipei, TWN, 10491
Gongwin Biopharm Holdings Co Ltd is a Taiwan-based biopharmaceutical company focused on developing novel anti-cancer drugs. The company develops products related to central lung serious tracheal obstruction, primary liver cancer, malignant pleural effusion, and tracheal adenoid cystic carcinoma. The Group includes pharmaceutical research and development, drug testing, pharmaceutical technology consulting, biotechnology services, technology transfer, and the sale of new drugs.
57GF Score

Get the complete analysis for ROCO:6617

FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$123.00
Price